FIELD: medicine.
SUBSTANCE: invention relates to new polycation-based bioconjugates of general formula I useful in delivery of various kinds of active substances into organism.
EFFECT: conjugates of increased activity and low toxicity.
36 cl, 4 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
DISULPHIDE-LINKED POLYETHYLENE GLYCOL/PEPTIDE CONJUGATES FOR NUCLEIC ACID TRANSFECTION | 2010 |
|
RU2552352C2 |
VACCINE AGAINST INTERMEDIATE WITH AMYLOID COAGULATION | 2009 |
|
RU2546234C2 |
IMMUNOSTIMULATOR INDUCING TUMOR-SPECIFIC IMMUNE CELLULAR RESPONSE AND METHOD FOR ITS PREPARING | 1996 |
|
RU2206329C2 |
COMBINATION OF ANTI-CANCER RNA VACCINE AND PD-1 PATHWAY INHIBITOR AND ITS APPLICATION | 2014 |
|
RU2718988C2 |
IMMUNOGENIC COMPOSITIONS | 2018 |
|
RU2791256C2 |
PHARMACEUTICAL STRUCTURES WITH INCREASED ALBUMIN BINDING AFFINITY | 2018 |
|
RU2753880C1 |
METHODS FOR OBTAINING BIOCONJUGATES FOR LIVER-SPECIFIC TARGETED MODULATION OF PROTEOME | 2022 |
|
RU2806913C1 |
CONJUGATES OF ERYTHROPOIETIN AND POLYETHYLENE GLYCOL, PHARMACEUTICAL COMPOSITIONS (VARIANTS), METHOD FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF DISTURBANCES AND METHOD FOR PREPARING CONJUGATE OR COMPOSITION | 2000 |
|
RU2232163C2 |
POLYMER-ASSISTED AMPLIFICATION OF VITAMIN B ABSORPTION SYSTEM | 1994 |
|
RU2139732C1 |
BIOCONJUGATIVE COMPLEXES, METHOD OF THEIR SYNTHESIS (VARIANTS), PHENYLBORATE COMPLEX- -FORMING CROSS-LINKING REAGENTS, KIT OF AGENTS OR SYSTEM, METHOD OF ISOLATION OF REQUIRED CELL POPULATION | 1995 |
|
RU2202555C2 |
Authors
Dates
2005-04-27—Published
2000-06-28—Filed